Pulmonologie

Our goal is to investigate the molecular mechanisms that control the proliferation and apoptosis of NSCLC cells and to elucidate the role of their microenvironment. Our research focuses on the availability of oxygen and substrates as well as metabolic and epigenetic changes.

Contact

Andelko Hrzenjak  
T: +43 316 385 73860
Forschung

Our Projects

  • Influence of hypoxia on tumor-growth and characterization of hypoxia-associated effects including molecular mechanisms of hypoxia-induced chemotherapy resistance
  • The role of histone-deacetylases and HDAC inhibitors as potential therapeutic approach for NSCLC
  • Relevance of microRNAs in chemotherapy-resistant hypoxic lung adenocarcinoma

Team

Cooperation partners

  • Division of Thoracic and Hyperbaric Surgery: Jörg Lindenmann
  • Diagnostic and Research Institute of Pathology: Helmuth Popper, Elivira Stacher-Priehse
  • Institute for Medical Informatics, Statistics and Documentation: Franz Quehenberger
  • Division of Molecular Biology and Biochemistry: Sara Frank